XML 107 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities:    
Income from continuing operations $ 21,089 $ 144,480
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization (including impairments) 454,198 427,536
Gain on investments, net (96,669) (177,438)
Loss on equity derivative contracts, net 52,510 127,331
Write-off of deferred financing costs 6,637 0
Amortization of deferred financing costs and discounts on indebtedness 13,432 19,350
Share-based compensation expense related to equity classified awards 28,292 23,681
Deferred income taxes 8,645 95,628
Provision for doubtful accounts 27,262 21,085
Changes in other assets and liabilities (13,830) (134,480)
Net cash provided by operating activities 501,566 547,173
Cash flows from investing activities:    
Capital expenditures (495,850) (464,423)
Proceeds related to sale of equipment, including costs of disposal 3,748 2,581
Decrease in restricted cash 0 573
Additions to other intangible assets (2,183) (1,322)
Net cash used in investing activities (494,285) (462,591)
Cash flows from financing activities:    
Proceeds from credit facility debt, net of discount 3,296,760 0
Repayment of credit facility debt (3,274,001) (44,762)
Repayment of senior notes 0 (87,822)
Proceeds from collateralized indebtedness 326,445 157,561
Repayment of collateralized indebtedness and related derivative contracts (288,108) (137,989)
Proceeds from stock option exercises 3,722 3,300
Dividend distributions to common stockholders (81,242) (86,020)
Principal payments on capital lease obligations (7,505) (4,638)
Deemed repurchases of restricted stock (11,384) (19,831)
Purchase of shares of CNYG Class A common stock, pursuant to a share repurchase program, held as treasury shares 0 (127,503)
Additions to deferred financing costs (26,535) (738)
Distributions to noncontrolling interests, net (250) (1,206)
Net cash used in financing activities (62,098) (349,648)
Net decrease in cash and cash equivalents from continuing operations (54,817) (265,066)
Cash flows of discontinued operations:    
Net cash provided by operating activities 224,528 42,877
Net cash used in investing activities (28,683) (47,988)
Net cash used in financing activities (38,735) (3,825)
Effect of change in cash related to discontinued operations 14,607 5,376
Net increase (decrease) in cash and cash equivalents from discontinued operations 171,717 (3,560)
Cash and cash equivalents at beginning of year 332,610 589,304
Cash and cash equivalents at end of period 449,510 320,678
CSC Holdings, LLC [Member]
   
Cash flows from operating activities:    
Income from continuing operations 104,004 214,524
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization (including impairments) 454,198 427,536
Gain on investments, net (96,669) (177,438)
Loss on equity derivative contracts, net 52,510 127,331
Write-off of deferred financing costs 6,637 0
Amortization of deferred financing costs and discounts on indebtedness 9,627 16,394
Share-based compensation expense related to equity classified awards 28,292 23,681
Deferred income taxes 30,738 128,546
Provision for doubtful accounts 27,262 21,085
Excess tax benefit on share-based awards (8,760) (4,373)
Changes in other assets and liabilities 54,454 (116,363)
Net cash provided by operating activities 662,293 660,923
Cash flows from investing activities:    
Capital expenditures (495,850) (464,423)
Proceeds related to sale of equipment, including costs of disposal 3,748 2,581
Decrease in restricted cash 0 573
Additions to other intangible assets (2,183) (1,322)
Net cash used in investing activities (494,285) (462,591)
Cash flows from financing activities:    
Proceeds from credit facility debt, net of discount 3,296,760 0
Repayment of credit facility debt (3,274,001) (44,762)
Repayment of senior notes 0 (60,997)
Proceeds from collateralized indebtedness 326,445 157,561
Repayment of collateralized indebtedness and related derivative contracts (288,108) (137,989)
Distributions to Cablevision (231,645) (426,543)
Excess tax benefit on share-based awards 8,760 4,373
Principal payments on capital lease obligations (7,505) (4,638)
Additions to deferred financing costs (26,535) (738)
Distributions to noncontrolling interests, net (250) (1,206)
Net cash used in financing activities (196,079) (514,939)
Net decrease in cash and cash equivalents from continuing operations (28,071) (316,607)
Cash flows of discontinued operations:    
Net cash provided by operating activities 224,528 42,877
Net cash used in investing activities (28,683) (47,988)
Net cash used in financing activities (38,735) (3,825)
Effect of change in cash related to discontinued operations 14,607 5,376
Net increase (decrease) in cash and cash equivalents from discontinued operations 171,717 (3,560)
Cash and cash equivalents at beginning of year 256,744 588,411
Cash and cash equivalents at end of period $ 400,390 $ 268,244